Globus Medical stock is currently trading approximately 33% below its 1-year high and is also trading at a PS multiple that ...

Globus Medical, Inc. (NYSE: GMED) has unveiled the ANTHEM™ Elbow Fracture System, a comprehensive plating platform designed ...

Data demonstrate ATH434 slows disease progression and stabilizes orthostatic hypotension –– New analysis increases overall confidence in the ...

Alterity Therapeutics (ATHE) announced that data from the ATH434-201 randomized, double-blind Phase 2 clinical trial in Multiple System Atrophy ...

The scans showed that people with schizophrenia had lower iron and myelin levels, especially in brain areas like the caudate, putamen, and globus pallidus. These regions are important for controlling ...

AUDUBON, Pa., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions ...

Globus Medical launched the Anthem Elbow Fracture System, a plating system designed to help surgeons manage a wide range of elbow fractures with simplified workflow and flexible fixation options.

Medtech company Globus Medical has introduced its Anthem Elbow Fracture System.  The system includes 14 plate families, 2.7mm and 3.5mm screw options and anatomy-specific reduction instruments, ...

The Argonne Leadership Computing Facility will host a virtual event on Wednesday, Oct. 15, for the first webinar in the ALCF’s new Service-Enabled Science training series: ALCF On-Demand: Integrated ...

Every week neurologist Victor Sung sees people with Huntington’s disease, a rare and devastating neurodegenerative disorder, at his clinic at the University of Alabama at Birmingham. But last ...

A gene therapy injected into patients’ brains slowed progression of the disease by 75 percent, preliminary findings reported. By Dana G. Smith Preliminary results from a small clinical trial to treat ...